Microfluidics-Based in Vivo Mimetic Systems for the Study of Cellular Biology

Abstract

ConspectusThe human body is a complex network of molecules, organelles, cells, tissues, and organs: an uncountable number of interactions and transformations interconnect all the system’s components. In addition to these biochemical components, biophysical components, such as pressure, flow, and morphology, and the location of all of these interactions play an important role in the human body. Technical difficulties have frequently limited researchers from observing cellular biology as it occurs within the human body, but some state-of-the-art analytical techniques have revealed distinct cellular behaviors that occur only in the context of the interactions. These types of findings have inspired bioanalytical chemists to provide new tools to better understand these cellular behaviors and interactions.What blocks us from understanding critical biological interactions in the human body? Conventional approaches are often too naïve to provide realistic data and in vivo whole animal studies give complex results that may or may not be relevant for humans. Microfluidics offers an opportunity to bridge these two extremes: while these studies will not model the complexity of the in vivo human system, they can control the complexity so researchers can examine critical factors of interest carefully and quantitatively. In addition, the use of human cells, such as cells isolated from donated blood, captures human-relevant data and limits the use of animals in research. In addition, researchers can adapt these systems easily and cost-effectively to a variety of high-end signal transduction mechanisms, facilitating high-throughput studies that are also spatially, temporally, or chemically resolved. These strengths should allow microfluidic platforms to reveal critical parameters in the human body and provide insights that will help with the translation of pharmacological advances to clinical trials.In this Account, we describe selected microfluidic innovations within the last 5 years that focus on modeling both biophysical and biochemical interactions in cellular communication, such as flow and cell–cell networks. We also describe more advanced systems that mimic higher level biological networks, such as organ on-a-chip and animal on-a-chip models. Since the first papers in the early 1990s, interest in the bioanalytical use of microfluidics has grown significantly. Advances in micro-/nanofabrication technology have allowed researchers to produce miniaturized, biocompatible assay platforms suitable for microfluidic studies in biochemistry and chemical biology. Well-designed microfluidic platforms can achieve quick, in vitro analyses on pico- and femtoliter volume samples that are temporally, spatially, and chemically resolved. In addition, controlled cell culture techniques using a microfluidic platform have produced biomimetic systems that allow researchers to replicate and monitor physiological interactions. Pioneering work has successfully created cell–fluid, cell–cell, cell–tissue, tissue–tissue, even organ-like level interfa...

Microfluidic platform for photodynamic therapy cytotoxicity analysis of nanoencapsulated indocyanine-type photosensitizers

“…This allows targeting of cells, for example, in accordance with the designed geometry of the microchannels, and control or evaluate of various cell behaviors as cell-cell interactions, or biochemical signaling. 8,10 The use of microfluidic systems for toxicity studies and cellular engineering is supported by a lot of examples. Huh et al presented a microfluidic system that reconstitutes the functional surface of the human lung and checked a possibility of its application in nanotoxicological tests.…”

Diffusion phenomena of cells and biomolecules in microfluidic devices

“…70 Many organ-on-a-chip platforms such as cardiac, vascular, brain, liver, lung, kidney, intestine, spleen, gut, muscle, and tumor have been introduced to test free and encapsulated forms of biomolecules as drug carrier systems. [71][72][73][74] (Figure 5). The objective of microfluidic in vitro 3D cancer models is to generate in vivo-like structures and functions in order to provide a more comprehensive understanding of complex interactions in the tumor microenvironment.…”

In Vitro Cerebrovascular Modeling in the 21st Century: Current and Prospective Technologies

“…Largely due to the advances in microfluidic technologies, recent progress in ‘organ-on-a-chip’ technology has been made towards the development of improved in vitro models capable of reproducing key human physiological responses, including multi organ interaction, with a significantly higher level of complexity than current platforms (194). The ‘human-on-a-chip’ system was conceptualized revolving around linking a variety of individual organ models together in a precise manner and using it as a platform to observe a drug's physiological effects on the body as a whole in vitro or to reproduce and monitor physiological interactions (193, 195). Such a predictive apparatus could revolutionize drug development and screening by more accurately clarifying the therapeutic and pathological side effects of a drug before costly in vivo or clinical trials are done, ultimately increasing drug development efficiency and quality while reducing costs.…”